Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial (Q36929714)
Jump to navigation
Jump to search
scientific article published on 14 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial |
scientific article published on 14 October 2013 |
Statements
1 reference
Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial (English)
1 reference
Hillard M Lazarus
1 reference
David A Rizzieri
1 reference
Edmund K Waller
1 reference
Steven M Devine
1 reference
Philippe Armand
1 reference
Arnon Nagler
1 reference
Edie A Weller
1 reference
David E Avigan
1 reference
Yi-Bin Chen
1 reference
Mark S Kaminski
1 reference
H Kent Holland
1 reference
James R Mason
1 reference
Joseph W Fay
1 reference
Edward D Ball
1 reference
Joseph P Uberti
1 reference
Markus Y Mapara
1 reference
Stephanie A Gregory
1 reference
John M Timmerman
1 reference
David Andorsky
1 reference
Reuven Or
1 reference
Rinat Rotem-Yehudar
1 reference
14 October 2013
1 reference
1 reference
4199-4206
1 reference
Identifiers
1 reference
1 reference
1 reference